Biologics & Smell in CRSwNP: Dupilumab, Tezepelumab, Beyond

.ical

09-11, 16:30–17:30 (Europe/Istanbul), Rhinology 1 (ICC - B2 level BEYAZIT)

Basile Landis

Johaim Mullol

Richard Harvey

This speaker also appears in:

• Type 2 CRSwNP in 2026: Global variations and decision-making process in the era of biologics

Claus Bachert

This speaker also appears in:

• CSR Pathophysiology Update 2026

Zara Patel

This speaker also appears in:

• Women in ORL
• Restoring Smell: Proven and Emerging Therapies

Marcio Nakanishi